The global cognitive behavioral therapy (CBT) market is poised for rapid growth, projected to expand from USD 9.01 billion in 2025 to approximately USD 34.25 billion by 2034, representing a compound annual growth rate (CAGR) of 15.99%. The surge is largely driven by the rising prevalence of mental health disorders worldwide and increasing awareness of therapy options.
According to a study by Towards Healthcare, a sister firm of Precedence Research, North America dominated the CBT market in 2024, while Asia Pacific is expected to register the fastest growth between 2025 and 2034. Within therapy types, cognitive therapy led the market in 2024 and is anticipated to continue strong growth.
By condition, depression accounted for the largest market share in 2024, whereas anxiety disorders are projected to grow at the fastest rate. Adults represent the primary consumer segment, though the geriatric population is expected to see notable growth over the coming decade. Among service providers, hospitals and clinics currently dominate, while home care services are expanding rapidly.
CBT is a form of psychotherapy that targets negative thinking patterns and behaviors, helping manage conditions such as anxiety, depression, PTSD, substance abuse, sleep disorders, and eating disorders. Innovations like CBT apps and remote therapy are broadening access, while the emergence of “third-wave” CBT emphasizes psychological flexibility and acceptance.
Market expansion is being propelled by rising mental health awareness, reduced stigma, and government and employer initiatives integrating CBT into healthcare and workplace wellness programs. Technological advancements, including digital platforms and mobile apps, are also making therapy more convenient, affordable, and personalized.
However, the market faces challenges, including high costs, limited access, engagement barriers with digital platforms, and data privacy concerns. Additionally, the structured, time-limited approach of CBT may not suit all patients, particularly those requiring interpersonal-focused therapy.
Recent industry developments highlight continued growth and innovation. In June 2025, OBIO helped A4i expand its presence in Canada through a partnership with Waypoint Centre for Mental Health Care. In March 2025, Greenspace Health secured Series B funding to advance behavioral health solutions using measurement-based care. Meanwhile, in May 2024, Aptar Digital Health and Iona Mind partnered to provide low-intensity CBT support for patients with chronic diseases.
With robust demand in North America and accelerating adoption in Asia Pacific, the global CBT market is set for significant expansion, driven by both technological innovation and growing recognition of mental health’s critical importance.
READ MORE
